News

The stock market is off to a rough start to 2025. It's never fun to see the value of your portfolio dwindle, and there's never any certainty about when a period of market volatility will end. But

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the

In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and recent updates impacting the semiconductor market. To learn more, check out the short video, consider

In today's video, I discuss Broadcom (NASDAQ: AVGO), Advanced Micro Devices (NASDAQ: AMD), and Taiwan Semiconductor Manufacturing (NYSE: TSM). To learn more, check out the short video, consider

Explore the exciting world of Advanced Micro Devices (NASDAQ: AMD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

There's no such thing as a completely "safe" stock, but some stocks are less risky than others. That's particularly true during times of extreme uncertainty and volatility. The major stock indices

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and recent updates investors should know. To learn more, check out the short video, consider subscribing, and click the special offer

Taiwan Semiconductor Manufacturing (NYSE: TSM) is the world's leading semiconductor (chip) foundry. Its foundry business model means it makes chips tailored to its customers' specific needs, and key

Although recent stock market volatility has pushed down prices for many stocks, the artificial intelligence (AI) sector remains a compelling investment, with the tremendous transformative potential

Equity markets recently dipped due to concerns of deteriorating macroeconomic conditions, with the latest trigger being President Trump's trade wars. The S&P 500 index's performance over the

Is the excitement surrounding chipmaker Nvidia fading? As of Monday, shares of the tech giant were down 19% since the start of 2025. Whether that's due to its high valuation, concerns about the

In this video, I will talk about recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

AT&T (NYSE: T) is often considered a slow-growth stock -- the kind of investment people hold for stable returns and dividends rather than market-beating gains. But over the past 12 months, the

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and

AT&T (NYSE: T) shareholders have plenty to celebrate, with the stock up 24% thus far in 2025. The telecommunications giant has presented robust earnings, reinforcing an optimistic long-term outlook

Dividend-paying stocks are hard to beat for income. If you're retired, you can use that money for your living expenses, and if you're still far from retirement, you might simply reinvest those

Forget stealth fighter jets, drones, and orbital, Earth-observing spy satellites. If you ask the U.S. Army, the future of Command, Control, Communications, Computers, Intelligence, Surveillance, and

One of the foundational pieces of the fast-growing artificial intelligence (AI) market has been the advanced semiconductors that make AI tools possible. Nvidia (NASDAQ: NVDA) has garnered the most

Artificial intelligence (AI) chip stocks are having a torrid time on the market in 2025, and that's not surprising. The sector has been hit hard by multiple headwinds of late, such as the viability

U.S. telecommunications giant AT&T (NYSE: T) has lulled investors to sleep with its poor performance over most of the past decade. But the stock has enjoyed a face-ripping rally over the past year

Uncertainty over the future of the U.S. economy has roiled the stock market, causing many stocks to sink. In this environment, telecom stocks present a potential reprieve. Society's dependence on

Summit Therapeutics (NASDAQ: SMMT) stock did better than a lot of other equities during an otherwise forgettable trading session on Wednesday. In contrast to other titles that fell notably, Summit

Lumen (NYSE: LUMN) stock got hit hard in Tuesday's trading. Its share price was down 10% just before market close on news that the company could wind up selling one of its units to AT&T. The stock